MedTrace Logo

Predicting Disease Progression and/or Recurrence in Cancer

NCT04776837 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 159

Last updated 2026-05-15

No results posted yet for this study

Summary

This is a prospective study addressing the challenge of predicting disease progression and/or recurrence in patients diagnosed with metastatic colorectal, pancreatobiliary, or esophagogastric cancer that are receiving anti-cancer therapy.

Conditions

Interventions

BEHAVIORAL

Observational Cohort

Patients will be followed by collecting clinical data, biospecimens, and quality of life assessment

Sponsors & Collaborators

Principal Investigators

  • Aparna R Parikh, MD, MS · Massachusetts General Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-15
Primary Completion
2021-11-19
Completion
2022-10-19

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04776837 on ClinicalTrials.gov